Three-Dimensional Correction Methods for Idiopathic Scoliosis in Adolescent (NCT07366996) | Clinical Trial Compass
Not Yet RecruitingNot Applicable
Three-Dimensional Correction Methods for Idiopathic Scoliosis in Adolescent
Egypt30 participantsStarted 2026-02-01
Plain-language summary
This study aims to compare the effectiveness of "Schroth method" and "Scientific Exercise Approach to Scoliosis" for correcting idiopathic scoliosis in adolescents.
Who can participate
Age range13 Years – 18 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Teenagers diagnosed with typical idiopathic scoliosis.
* Teenagers aged 13 to 18 years
* Both genders will be included.
* Participants with a Cobb angle ranging from 10° to 25°, as determined by radiographic analysis.
* Participants with Risser sign of 2 to 3, indicating incomplete skeletal maturity.
* Participants must be able to understand and follow instructions, ensuring effective participation in the treatment protocol.
Exclusion Criteria:
* Adolescents with significant visual or auditory impairments that could interfere with the ability to participate in or benefit from the rehabilitation programs.
* Adolescents with cognitive, mental, or psychological disorders that hinder understanding or following the instructions necessary for the treatment protocol.
* Adolescents who have previously undergone spinal surgery or any surgical interventions related to scoliosis or other spinal conditions.
* Adolescents with non-idiopathic scoliosis or scoliosis secondary to other underlying conditions (e.g., neuromuscular, congenital, or syndromic scoliosis).
* Adolescents with fixed spinal deformities that are not amenable to correction through non-surgical 3D approach.
* Adolescents with concurrent musculoskeletal conditions that could interfere with the treatment or assessment of scoliosis (e.g., significant hip or knee deformities).
* Adolescents currently participating in other clinical trials or receiving treatments that might confound the study results.